Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$336M |
| 2 |
Truist Financial
TFC
|
+$144M |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$103M |
| 4 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$91.6M |
| 5 |
Home Depot
HD
|
+$90.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$323M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$136M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$56.6M |
| 4 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$41.5M |
| 5 |
VSM
Versum Materials, Inc.
VSM
|
+$39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.04% |
| 2 | Financials | 14.33% |
| 3 | Healthcare | 12.99% |
| 4 | Industrials | 10.19% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MLNX
2251
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $3.17M | ﹤0.01% |
27,093
-456
| -2% | -$51.8K |
|
2252
W&T Offshore
WTI
$546M
| $3.16M | ﹤0.01% |
567,920
+13,350
| +2% | +$59.4K |
|
|
MITT
2253
TPG Mortgage Investment Trust
MITT
$214M
| $3.16M | ﹤0.01% |
68,219
+1,062
| +2% | +$49K |
|
2254
Assembly Biosciences
ASMB
$594M
| $3.15M | ﹤0.01% |
12,849
+2,434
| +23% | +$448K |
|
2255
Alector
ALEC
$228M
| $3.14M | ﹤0.01% |
182,374
+4,022
| +2% | +$68.4K |
|
2256
Regional Management Corp
RM
$301M
| $3.14M | ﹤0.01% |
104,455
-28,434
| -21% | -$862K |
|
2257
Q32 Bio
QTTB
$458M
| $3.14M | ﹤0.01% |
8,417
+151
| +2% | +$43.2K |
|
2258
Powell Industries
POWL
$7.43B
| $3.12M | ﹤0.01% |
190,968
+951
| +0.5% | +$13.3K |
|
|
KREF
2259
KKR Real Estate Finance Trust
KREF
$502M
| $3.12M | ﹤0.01% |
152,532
+3,252
| +2% | +$65K |
|
2260
State Street SPDR Bloomberg International Treasury Bond ETF
BWX
$1.31B
| $3.11M | ﹤0.01% |
107,885
| – | – |
|
2261
OraSure Technologies
OSUR
$277M
| $3.1M | ﹤0.01% |
385,955
+18,706
| +5% | +$151K |
|
2262
Live Oak Bancshares
LOB
$2.01B
| $3.1M | ﹤0.01% |
162,864
+11,725
| +8% | +$217K |
|
|
BSTC
2263
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $3.08M | ﹤0.01% |
54,134
+5,541
| +11% | +$294K |
|
|
PENG
2264
Penguin Solutions Inc
PENG
$3.12B
| $3.08M | ﹤0.01% |
162,118
+4,778
| +3% | +$74K |
|
2265
Caesarstone
CSTE
$105M
| $3.07M | ﹤0.01% |
203,795
+44,277
| +28% | +$710K |
|
2266
Phibro Animal Health
PAHC
$1.38B
| $3.07M | ﹤0.01% |
123,625
+470
| +0.4% | +$10.9K |
|
|
STML
2267
DELISTED
Stemline Therapeutics, Inc.
STML
| $3.06M | ﹤0.01% |
287,844
+12,563
| +5% | +$125K |
|
|
VIA
2268
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $3.05M | ﹤0.01% |
66,145
| – | – |
|
2269
Goosehead Insurance
GSHD
$2.39B
| $3.05M | ﹤0.01% |
71,895
+1,325
| +2% | +$58.6K |
|
|
CONN
2270
DELISTED
Conn's Inc.
CONN
| $3.05M | ﹤0.01% |
246,017
+6,131
| +3% | +$128K |
|
2271
Weibo
WB
$1.88B
| $3.05M | ﹤0.01% |
65,758
+3,588
| +6% | +$168K |
|
2272
Anterix
ATEX
$1.79B
| $3.05M | ﹤0.01% |
70,513
+2,755
| +4% | +$112K |
|
|
CPRX
2273
DELISTED
Catalyst Pharmaceutical
CPRX
| $3.04M | ﹤0.01% |
809,820
+238,842
| +42% | +$1.12M |
|
|
SINA
2274
DELISTED
Sina Corp
SINA
| $3.04M | ﹤0.01% |
76,035
+758
| +1% | +$29.1K |
|
2275
Option Care Health
OPCH
$3.61B
| $3.03M | ﹤0.01% |
203,326
+9,850
| +5% | +$133K |
|
Similar funds
Charles Schwab's Q4 2019 Portfolio in Review
As of Q4 2019, Charles Schwab held 3,227 positions worth $186B, up 9.8% from $169B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 3%. Charles Schwab opened 50 new positions and exited 48, leaving the 3,227-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2019 buy was Apollo Global Management: 821,197 shares worth $39.2M.
- Charles Schwab added most to Bristol-Myers Squibb in Q4 2019, an estimated $336M increase.
- Charles Schwab's biggest Q4 2019 reduction was Bank of America, cutting an estimated $34M.
- Charles Schwab fully exited Celgene Corp in Q4 2019, selling an estimated $323M.
- Charles Schwab's ten largest holdings make up 16% of its $186B portfolio in Q4 2019.
- Charles Schwab opened 50 new positions and closed 48 in Q4 2019.
- Charles Schwab's portfolio value rose 9.8% quarter-over-quarter to $186B.
Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.